EUVIMEDEUVIMED entdecken
Crossref

A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor‐specific anti HLA antibodies

Sandra García-Jiménez, Estela Paz-Artal, Hernando Trujillo, Natalia Polanco, María J Castro, Manuel J Del Rey, Ángel Alfocea, Enrique Morales, Esther González, Amado Andrés, Esther Mancebo iD

HLA · 2024-06 · 103 (6)

DOI: 10.1111/tan.15572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, online erschienen am 24.06.2024. Verfasst von Sandra García-Jiménez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, University Hospital 12 de Octubre, Research Institute Hospital 12 Octubre (imas12), Madrid, Spain. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, HLA Antigens, Isoantibodies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Sociedad Madrileña de Trasplantes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates kidney transplant outcomes in highly sensitised patients after implementing a delisting strategy aimed at enabling transplantation despite preformed donor‐specific antibodies (preDSA), with the goal of reducing acute antibody‐mediated rejection (aAMR) risk. Fifty‐three sensitised recipients underwent kidney transplant after delisting prohibited HLA antigens, focusing initially in low MFI antibodies (5000. The highest MFI DSA were against HLA‐DP (Median: 10796 MFI), with 50% of preDSA aAMR cases due to anti‐DP antibodies ( n = 3). Graft survival rates at 1 and 5 years in preDSA group were 94%, and 67%, comparable to SwoDSA (94%, and 70%; p = 0.69), being significantly higher in the NS group ( p = 0.002). The five‐year recipient survival rate was 89%, comparable to SwoDSA and NS groups ( p = 0.79). A delisting strategy enables safe kidney transplant in highly sensitised patients with preDSA, with a slight increase in aAMR and comparable graft and patient survivals to non‐DSA cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGraft RejectionHLA AntigensIsoantibodiesGraft SurvivalTissue DonorsHumansMaleMiddle AgedFemaleAdultHistocompatibility TestingPrecision MedicineAged

Stichwörter der Autor:innen

antibody‐mediated rejectiondelisting strategyhighly sensitised patientskidney transplantationpreformed donor‐specific antibodies (preDSA)

Substanzen

HLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Immunology Department, University Hospital 12 de Octubre, Research Institute Hospital 12 Octubre (imas12), Madrid, Spain.
  • School of Medicine, Complutense University of Madrid, Madrid, Spain.
  • Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Nephrology Department, University Hospital 12 de Octubre, Research Institute Hospital 12 Octubre (imas12), Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Esther Mancebo

Förderung

  • Sociedad Madrileña de Trasplantes

Zitieren

APA

García-Jiménez, S., Paz-Artal, E., Trujillo, H., Polanco, N., Castro, M. J., Del Rey, M. J., Alfocea, Á., Morales, E., González, E., Andrés, A., & Mancebo, E. (2024). A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor‐specific anti HLA antibodies. HLA, 103(6). https://doi.org/10.1111/tan.15572

Vancouver

García-Jiménez S, Paz-Artal E, Trujillo H, Polanco N, Castro MJ, Del Rey MJ, et al. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor‐specific anti HLA antibodies. HLA. 2024;103(6). doi:10.1111/tan.15572

BibTeX
@article{GarcaJimnez2024,
  author = {García-Jiménez, Sandra and Paz-Artal, Estela and Trujillo, Hernando and Polanco, Natalia and Castro, María J and Del Rey, Manuel J and Alfocea, Ángel and Morales, Enrique and González, Esther and Andrés, Amado and Mancebo, Esther},
  title = {A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor‐specific anti HLA antibodies},
  journal = {HLA},
  year = {2024},
  volume = {103},
  number = {6},
  doi = {10.1111/tan.15572}
}
Kostenlos starten →